NF-IL6 (C/EBPβ) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 39, 2008, Pages 15022-15027

  Kinoshita, Shigemi M ^a   Taguchi, Shizuka ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CCAAT ENHANCER BINDING PROTEIN BETA; CYTIDINE DEAMINASE; VIF PROTEIN; APOBEC3G PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEAMINATION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS STRAIN; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CCAAT-ENHANCER-BINDING PROTEIN-BETA; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTIDINE DEAMINASE; HIV-1; HUMANS; VIRUS REPLICATION;

EID: 54449088434     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0807269105     Document Type: Article

References (41)

1. Folks T, et al. (1986) Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J Immunol 136:4049-4053.
2. Zack JA, et al. (1990) HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
3. Kinoshita S, et al. (1997) The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6:235-244.
4. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
5. Jarmuz A, et al. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79:285-296.
6. Muto T, Muramatsu M, Taniwaki M, Kinoshita K, Honjo T (2000) Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68:85-88.
7. Mangeat B, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
8. Rosler C, Kock J, Malim MH, Blum HE, von Weizsacker F (2004) Comment on "Inhibition of hepatitis B virus replication by APOBEC3G." Science 305:1403.
9. Chen H, et al. (2006) APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 16:480-485.
10. Harris RS, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
11. Zhang H, et al. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98.
12. Lecossier D, Bouchonnet F, Clavel F, Hance AJ (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112.
13. Marin M, Rose KM, Kozak SL, Kabat D (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9:1398-1403.
14. Sheehy AM, Gaddis NC, Malim MH (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-1407.
15. Mariani R, et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31.
16. Sasada A, et al. (2005) APOBEC3G targets human T-cell leukemia virus type 1. Retrovirology 2:32.
17. Russell RA, et al. (2005) Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol 79:8724-8731.
18. Akira S, et al. (1990) A nuclear factor for IL-6 expression (NF-IL6) is amember of a C/EBP family. EMBO J 9:1897-1906.
19. Akira S, Kishimoto T (1997) NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol 65:1-46.
20. Nakajima T, et al. (1993) Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 90:2207-2211.
21. Matsusaka T, et al. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90:10193-10197.
22. Kinoshita S, Chen BK, Kaneshima H, Nolan GP (1998) Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95:595-604.
23. von Schwedler U, Song J, Aiken C, Trono D (1993) Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol 67:4945-4955.
24. Henderson AJ, Zou X, Calame KL (1995) C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/ monocytes. J Virol 69:5337-5344.
25. Tesmer VM, Rajadhyaksha A, Babin J, Bina M (1993) NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90:7298-7302.
26. Buckner AE, Tesmer VM, Bina M (2002) Regulation of HIV-1 transcription by NF-IL6 in activated Jurkat T cells. Virus Res 89:53-63.
27. Buck M, Zhang L, Halasz NA, Hunter T, Chojkier M (2001) Nuclear export of phosphorylated C/EBPβ mediates the inhibition of albumin expression by TNF-α. EMBO J 20:6712-6723.
28. Strebel K, et al. (1987) The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328:728-730.
29. Gabuzda DH, et al. (1992) Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol 66:6489-6495.
30. Camaur D, Trono D (1996) Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J Virol 70:6106-6111.
31. Heinzinger NK, et al. (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91:7311-7315.
32. Natsuka S, et al. (1992) Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79:460-466.
33. Cron RQ, et al. (2000) NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Clin Immunol 94:179-191.
34. Macian F, Lopez-Rodriguez C, Rao A (2001) Partners in transcription: NFAT and AP-1. Oncogene 20:2476-2489.
35. Martin A, et al. (2002) Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415:802-806.
36. Muramatsu M, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563.
37. Okazaki IM, et al. (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197:1173-1181.
38. Komohara Y, et al. (2007) Expression of APOBEC3G in kidney cells. Tissue Antigens 69:95-98.
39. Di Noia J, Neuberger MS (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419:43-48.
40. Martin A, Scharff MD (2002) AID and mismatch repair in antibody diversification. Nat Rev Immunol 2:605-614.
41. Hitoshi Y, et al. (1998) Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8:461-471.